Showing 1 - 10 results of 10 for search '"Fumagalli, Riccardo M"', query time: 1.66s Refine Results  

Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial

by Fumagalli, Riccardo M., Voci, Davide, Bikdeli, Behnood, Bingisser, Roland, Colucci, Giuseppe, Forgo, Gabor, Gerardi, Teresa, Gerber, Bernhard, Grigorean, Alexandru, Klok, Frederikus A., Righini, Marc, Robert-Ebadi, Helia, Stortecky, Stefan, Ulrich, Silvia, Wolf, Simon, Wyss, Dörte, Hobohm, Lukas, Kucher, Nils, Barco, Stefano, Barco, Stefano, Voci, Davide, Held, Ulrike, Sebastian, Tim, Bingisser, Roland, Colucci, Giuseppe, Duerschmied, Daniel, Frenk, André, Gerber, Bernhard, Götschi, Andrea, Konstantinides, Stavros V., Mach, François, Robert-Ebadi, Helia, Rosemann, Thomas, Simon, Noemi R., Spechbach, Hervé, Spirk, David, Stortecky, Stefan, Vaisnora, Lukas, Righini, Marc, Kucher, Nils, Zetzsche, Stéphanie Roth, Spescha, Rebecca, Leeger, Claudia, Butscheid, Yulia, Probst, Eliane, Micieli, Evy, Forgo, Gabor, Johner, Fabian, Grigorean, Alexandru, Vatsakis, Georgios, Lang, Dagmar Keller, Speck, Silvana Rampini, Hasse, Barbara, Rueegg, Marco, Arnold, Isabelle, Nickel, Christian, Busch, Jeannette, Blondon, Marc, Glauser, Frédéric, Cittone, Micol G., Kessler, Chiara, Gjermeni, Diona, Olivier, Christoph B., Gauchel, Nadine, Biever, Paul, Hobohm, Lukas, Becker, Dorothea, Schindewolf, Marc, Kuenzi, Arnaud, Ulrich, Silvia
Published in Research and practice in thrombosis and haemostasis (01.07.2024)

Get full text
Journal Article